Evolva is a biotech company that develops and commercializes ready-to-formulate and nature-based ingredients.
Evolva is a biotech company that develops and commercializes ready-to-formulate and nature-based ingredients. Evolva was founded in 2004 around a distinctive, proprietary, technology platform that uses synthetic biology to create innovative small-molecule drugs and other compounds. In particular, their platform allows the creation of chemistries that recapitulate the themes found in natural products, but without the disadvantages of those approaches.The company is headquartered in Reinach, Switzerland.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 11, 2009 | Post-IPO Equity | $27.50M | 1 | — | — | Detail |
Oct 22, 2009 | Series B | Fr28M | 1 | — | — | Detail |
Dec 1, 2006 | Series A | $10.30M | 2 | — | — | Detail |
Mar 21, 2005 | Series A | €2M | 2 | — | — | Detail |
Aug 16, 2004 | Series A | €12M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Dansk Innovation | — | Post-IPO Equity |
Yamanouchi Venture Capital | — | Series A |